Articles published in Journal of Diabetes & Metabolism have been cited by esteemed scholars and scientists all around the world. Journal of Diabetes & Metabolism has got h-index 43, which means every article in Journal of Diabetes & Metabolism has got 43 average citations.
Following are the list of articles that have cited the articles published in Journal of Diabetes & Metabolism.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
Total published articles |
123 | 107 | 59 | 61 | 45 | 23 |
Research, Review articles and Editorials |
44 | 54 | 37 | 40 | 21 | 22 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
5 | 1 | 2 | 5 | 3 | 0 |
Conference proceedings |
6 | 16 | 5 | 7 | 0 | 45 |
Citations received as per Google Scholar, other indexing platforms and portals |
632 | 946 | 1156 | 1199 | 1039 | 1106 |
| Journal total citations count | 10648 |
| Journal impact factor | 12.50 |
| Journal 5 years impact factor | 18.23 |
| Journal cite score | 23.62 |
| Journal h-index | 43 |
| Journal Impact Factor 2020 formula |
| IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year |
| Journal 5-year Impact Factor 2020 formula |
| Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)} |
| Journal citescore |
| Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3 |
Roh JG, Yoon JS, Park KJ, Lim JS, Lee HS, Hwang JS. Evaluation of bone mineral status in prepuberal children with newly diagnosed type 1 diabetes. Annals of pediatric endocrinology & metabolism. 2018 Sep;23(3):136. |
|
Zhao J, Yang H, Chen B, Zhang R. The skeletal renin-angiotensin system: A potential therapeutic target for the treatment of osteoarticular diseases. International immunopharmacology. 2019 Jul 1;72:258-63. |
|
Jackuliak P, Kužma M, Payer J. Effect of Antidiabetic Treatment on Bone. Physiological Research. 2019 Sep 2;68. |
|
Brunetti G, D’Amato G, Chiarito M, Tullo A, Colaianni G, Colucci S, Grano M, Faienza MF. An update on the role of RANKL–RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases. World Journal of Pediatrics. 2019 Feb 4;15(1):4-11. |
|
PODDAR NK, Mueed Z, Tandon P, Maurya S, Deval R, Kamal MA. Tau and mTOR: The hotspots for multifarious diseases in Alzheimer’s development. Frontiers in neuroscience. 2018;12:1017. |
|
赵花, å¼ ä¸½ä¾ , 郑丽丽. 2 型糖尿病患者血糖控制水平对骨密度的影å“. 郑州大å¦å¦æŠ¥: 医å¦ç‰ˆ. 2015(1):124-7. |
|
Maalouf NM. Impact of anti-hyperglycemic medications on bone health. Clinical Reviews in Bone and Mineral Metabolism. 2015 Mar 1;13(1):43-52. |
|
Franceschi R, Longhi S, Cauvin V, Fassio A, Gallo G, Lupi F, Reinstadler P, Fanolla A, Gatti D, Radetti G. Bone geometry, quality, and bone markers in children with type 1 diabetes mellitus. Calcified tissue international. 2018 Jun 1;102(6):657-65. |
|
Kalyanaraman H, Schwaerzer G, Ramdani G, Castillo F, Scott BT, Dillmann W, Sah RL, Casteel DE, Pilz RB. Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes. Diabetes. 2018 Apr 1;67(4):607-23. |
|
Zhukouskaya VV, Shepelkevich AP, Chiodini I. Bone health in type 1 diabetes: where we are now and how we should proceed. Advances in Endocrinology. 2014;2014. |
|
Nel JD, Epstein S. Metabolic bone disease in the post-transplant population: preventative and therapeutic measures. Medical Clinics. 2016 May 1;100(3):569-86. |
|
Kalaitzoglou E, Fowlkes JL, Popescu I, Thrailkill KM. Diabetes pharmacotherapy and effects on the musculoskeletal system. Diabetes/metabolism research and reviews. 2019 Feb;35(2):e3100. |
|
Dicarlo M, Bianchi N, Ferretti C, Orciani M, Di Primio R, Mattioli-Belmonte M. Evidence supporting a paracrine effect of IGF-1/VEGF on human mesenchymal stromal cell commitment. Cells Tissues Organs. 2016;201(5):333-41. |
|
Fowlkes JL, Nyman JS, Bunn RC, Cockrell GE, Wahl EC, Rettiganti MR, Lumpkin Jr CK, Thrailkill KM. Effects of long-term doxycycline on bone quality and strength in diabetic male DBA/2J mice. Bone reports. 2015 Jan 1;1:16-9. |
|
Guo Y, Tang CY, Man XF, Tang HN, Tang J, Wang F, Zhou CL, Tan SW, Feng YZ, Zhou HD. Insulin receptor substrate-1 time-dependently regulates bone formation by controlling collagen Iα2 expression via miR-342. The FASEB Journal. 2016 Sep 13;30(12):4214-26. |
|
Ma H, Ma JX, Xue P, Gao Y, Li YK. Osteoblast proliferation is enhanced upon the insulin receptor substrate 1 overexpression via PI3K signaling leading to down-regulation of NFκB and BAX pathway. Experimental and Clinical Endocrinology & Diabetes. 2015 Feb;123(02):126-31. |
|
Magri AM, Fernandes KR, Assis L, Mendes NA, da Silva Santos AL, de Oliveira Dantas E, Rennó AC. Photobiomodulation and bone healing in diabetic rats: evaluation of bone response using a tibial defect experimental model. Lasers in medical science. 2015 Sep 1;30(7):1949-57. |
|
RÅ‘szer T, Józsa T, Kiss-Tóth ÉD, De Clerck N, Balogh L. Leptin receptor deficient diabetic (db/db) mice are compromised in postnatal bone regeneration. Cell and tissue research. 2014 Apr 1;356(1):195-206. |
|
Ferretti C, Vozzi G, Falconi M, Orciani M, Gesi M, Di Primio R, Mattioli-Belmonte M. Role of IGF1 and IGF1/VEGF on human mesenchymal stromal cells in bone healing: two sources and two fates. Tissue Engineering Part A. 2014 Apr 2;20(17-18):2473-82. |
|
Faienza MF, Ventura A, Delvecchio M, Fusillo A, Piacente L, Aceto G, Colaianni G, Colucci S, Cavallo L, Grano M, Brunetti G. High Sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism. 2016 Oct 12;102(4):1174-81. |
|
